Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics

Detalles Bibliográficos
Autores principales: Wax, P.M., Aldy, K., Brent, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461783/
http://dx.doi.org/10.1016/S0378-4274(21)00280-0
_version_ 1784572066702295040
author Wax, P.M.
Aldy, K.
Brent, J.
author_facet Wax, P.M.
Aldy, K.
Brent, J.
collection PubMed
description
format Online
Article
Text
id pubmed-8461783
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier B.V. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-84617832021-09-24 Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics Wax, P.M. Aldy, K. Brent, J. Toxicol Lett Article Published by Elsevier B.V. Published by Elsevier B.V. 2021-09 2021-09-24 /pmc/articles/PMC8461783/ http://dx.doi.org/10.1016/S0378-4274(21)00280-0 Text en Copyright © 2021 Published by Elsevier B.V. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wax, P.M.
Aldy, K.
Brent, J.
Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics
title Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics
title_full Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics
title_fullStr Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics
title_full_unstemmed Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics
title_short Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics
title_sort rapid development of the fda acmt covid-19 toxic (fact) pharmacovigilance pilot project to monitor adverse events reported in association with covid-19 therapeutics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461783/
http://dx.doi.org/10.1016/S0378-4274(21)00280-0
work_keys_str_mv AT rapiddevelopmentofthefdaacmtcovid19toxicfactpharmacovigilancepilotprojecttomonitoradverseeventsreportedinassociationwithcovid19therapeutics
AT waxpm rapiddevelopmentofthefdaacmtcovid19toxicfactpharmacovigilancepilotprojecttomonitoradverseeventsreportedinassociationwithcovid19therapeutics
AT aldyk rapiddevelopmentofthefdaacmtcovid19toxicfactpharmacovigilancepilotprojecttomonitoradverseeventsreportedinassociationwithcovid19therapeutics
AT brentj rapiddevelopmentofthefdaacmtcovid19toxicfactpharmacovigilancepilotprojecttomonitoradverseeventsreportedinassociationwithcovid19therapeutics

Ejemplares similares